Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2026-03-31 @ 6:02 PM
Study NCT ID:
NCT00337103
Status:
COMPLETED
Last Update Posted:
2020-06-18
First Post:
2006-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
Sponsor:
Eisai Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
E7389-G000-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None